Pramosone
NDC Package 54766-726-75

11-digit billing NDC: 54766072675

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Pramosone is iNDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Marketed by Sebela Pharmaceuticals Inc., this product is identified by NDC 54766-726 and is authorized under FDA application ANDA085979.

Identification & Billing

NDC Package Code
54766-726-75
Package Description
12 BOTTLE, PLASTIC in 1 BOX / 7.5 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
54766072675

Clinical Specifications

Proprietary Name
Pramosone
Dosage Form
-
Usage Information
INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Regulatory & Marketing

Labeler Name
Sebela Pharmaceuticals Inc.
FDA Application #
ANDA085979
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-16-2014
End Marketing Date
08-31-2026
Listing Expiration
08-31-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (54766-726). Click a package code to view its specific billing and regulatory data.

118 mL in 1 BOTTLE, PLASTIC
59 mL in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54766-726-75 identifies a specific commercial package of 12 bottle, plastic in 1 box / 7.5 ml in 1 bottle, plastic of Pramosone, labeled by Sebela Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sebela Pharmaceuticals Inc. on October 16, 2014. The current certification is valid through August 31, 2026.

How is this Sebela Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54766072675. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54766-726-75
11-Digit CMS (5-4-2)
54766-0726-75

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.